Rankings
▼
Calendar
CPRX FY 2025 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$589M
+19.8% YoY
Gross Profit
$502M
85.2% margin
Operating Income
$258M
43.8% margin
Net Income
$214M
36.4% margin
EPS (Diluted)
$1.68
Cash Flow
Operating Cash Flow
$209M
Free Cash Flow
$209M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$150M
Stockholders' Equity
$954M
Cash & Equivalents
$709M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$589M
$492M
+19.8%
Gross Profit
$502M
$423M
+18.6%
Operating Income
$258M
$195M
+32.1%
Net Income
$214M
$164M
+30.8%
← Q4 2024
All Quarters
Q1 2025 →